Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

NCT04683848 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinal Cord Injury

Interventions

BIOLOGICAL: MT-3921
BIOLOGICAL: Placebo

Sponsor

Tanabe Pharma America, Inc.